July 16, 2019
Industry Non-CME Program lineup announcedDon’t miss this year’s Industry non-CME (INC) Programs being held July 26-27, 2019, in New York. Held concurrently during the AAD 2019 Summer Meeting, the informational programs do not qualify for CME credit. > MORE 
Clinical Issues in Atopic Dermatitis: Debates and Discussions About Managing Moderate-to-Severe DiseaseRegistration: 6:30 p.m.
Session: 7-9 p.m., Friday, July 26 (Dinner is provided.)
Facility: Sheraton New York Times Square Hotel
Room: New York West Ballroom
Sponsor: Integratis Communications
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Program Overview: This Clinical Issues™ program will discuss pathophysiologic underpinnings of atopic dermatitis, considerations related to evaluating patients, and therapeutic strategies for cases of moderate-to-severe disease. Pre-registration is provided for this INC Program and may be found at www.exchangecme.com/ADNYC. > MORE
Dupixent® (dupilumab): Now Approved for an Expanded IndicationRegistration: 7 p.m.
Session: 7-8:30 p.m., Saturday, July 27 (Food and beverage is provided.)
Facility: New York Hilton Midtown
Room: Grand Ballroom West
Sponsor: Regeneron and Sanofi Genzyme
Exhibit Hall Booth Number: 728
Program Overview: DUPIXENT is approved by the FDA. Learn about its clinical efficacy, safety, MOA, dosing, and administration. Pre-register by emailing dermatologyevents@significantmeetings.com or calling 973-500-2068. > MORE
Are Your Patients Systemic-Ready? An Oral Treatment Option for Moderate-to-Severe Plaque PsoriasisIndustry Theater: 12-12:45 p.m.
Facility: Americas Halls 2
Host: Celgene
Description: Leon Kircik, MD, will present a current oral, non-biologic treatment option in moderate-to-severe plaque psoriasis. > MORE
